A 1-week washout is generally sufficient because the half-life of subcutaneous retatrutide in the phase 2 trial was approximately 6 days, meaning drug concentrations fall to below 5% of steady state within roughly 25 days [1, 17]
Many patients follow the program for several months, then reassess with their provider about continuing, adjusting, or transitioning to maintenance
Pinto-Hernandez P, Fernandez-Sanjurjo M, Paget D, Caravia XM, Roiz-Valle D, Castilla-Silgado J, et al
Durante el embarazo existe inters cientfico por las funciones de la creatina en el metabolismo energtico materno y fetal, pero la evidencia clnica todava no permite recomendar su suplementacin rutinaria sin supervisin